Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.670
+0.180 (4.01%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $25.24 million as of June 8, 2026. Its market cap has increased by 142.77% in one year.
Market Cap
25.24M
Enterprise Value
5.83M
1-Year Change
142.77%
Ranking
Category
Stock Price
$4.67
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $25.24M, an increase of 133.94%. That is a compound annual growth rate of 79.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 24.27M | 16.31% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 26.64M |
| NeuroSense Therapeutics | 26.52M |
| Dyadic International | 25.89M |
| Skye Bioscience | 25.76M |
| Lite Strategy | 25.48M |
| Pluri | 25.46M |
| Celularity | 25.25M |
| Allarity Therapeutics | 24.89M |